Methods and compositions for regulatory t-cell ablation
AssigneeSloan-Kettering Institute for Cancer Research
InventorsPaula D. Bos, Alexander Rudensky
Life of this patent
Estimating the term…
Abstract
The present invention provides, among other things, methods and compositions for the treatment of cancer. The present invention is based, in part, on the surprising discovery that ablation of regulatory T cells (Treg), for example, transient ablation of Treg, is able to drastically reduce tumor burden and reduce metastasis when used as a single agent. In some embodiments, provided methods and compositions are used in combination with one or more other anti-tumor therapies, for example, ionizing radiation.
Claims27
A method of treating cancer comprising ablating regulatory t-cells (Treg) in a subject who is suffering from or susceptible to cancer.
Dependencies are inferred from the claim text.